The F-35 Joint Strike Fighter Program, and More from CRS
The F-35 Joint Strike Fighter is the single largest procurement program in the Department of Defense, which anticipates acquiring thousands of these aircraft.
But while “the F-35 promises significant advances in military capability…, reaching that capability has put the program above its original budget and behind the planned schedule,” according to the Congressional Research Service. See F-35 Joint Strike Fighter (JSF) Program, updated April 13, 2018.
Other new and updated CRS reports that have not been made publicly available include the following.
FY2018 Defense Appropriations Act: An Overview, CRS In Focus, April 5, 2018
The President’s FY2019 Military Construction Budget Request, CRS In Focus, April 4, 2018
Legal Authorities Under the Controlled Substances Act to Combat the Opioid Crisis, April 16, 2018
Regulatory Reform 10 Years After the Financial Crisis: Dodd-Frank and Securities Law, April 13, 2018
Offshore Oil and Gas Development: Legal Framework, updated April 13, 2018
NASA Appropriations and Authorizations: A Fact Sheet, updated April 16, 2018
Special Counsels, Independent Counsels, and Special Prosecutors: Legal Authority and Limitations on Independent Executive Investigations, updated April 13, 2018
Cuba After the Castros, CRS Insight, April 17, 2018
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.